Jazz Pharmaceuticals
JAZZ
#1410
Rank
NZ$27.01 B
Marketcap
NZ$420.92
Share price
-2.62%
Change (1 day)
33.67%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2026 (TTM): NZ$6.07

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$6.64. In 2025 the company made an earnings per share (EPS) of NZ-$10.58 a decrease over its 2024 EPS that were of NZ$16.65.

EPS history for Jazz Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.07-157.32%
2025NZ-$10.58-163.56%
2024NZ$16.6539.08%
2023NZ$11.97-285.03%
2022NZ-$6.47-34.2%
2021NZ-$9.83-224.83%
2020NZ$7.88-53.25%
2019NZ$16.8523.59%
2018NZ$13.64-8.24%
2017NZ$14.8623.74%
2016NZ$12.0122.12%
2015NZ$9.83478.49%
2014NZ$1.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.60 44.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
NZ$15.15 128.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
NZ-$1.96-129.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
NZ$0.82-87.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel